@vcclibrary.bsky.socialPreliminary results of the STARLORD study: a mono-institutional prospective phase II experience of STereotActic Radiotherapy for LOcally advanced non-small cell #LungCancer ineligible for concurrent chemoRaDiation. www.clinicaloncologyonline.net/article/S093...
@btog.bsky.socialFunding competition: Innovate UK invests £25.4M to advance early cancer diagnosis. Apply by 28 Oct 2026! https://ow.ly/TeNx50ZCn3G #LCSM #LungCancer
@readbentham.bsky.social𝐃𝐫𝐢𝐯𝐞𝐫 𝐆𝐞𝐧𝐞𝐬 𝐚𝐧𝐝 𝐆𝐞𝐧𝐨𝐦𝐢𝐜 𝐈𝐧𝐬𝐭𝐚𝐛𝐢𝐥𝐢𝐭𝐲 𝐢𝐧 𝐁𝐫𝐚𝐢𝐧 𝐌𝐞𝐭𝐚𝐬𝐭𝐚𝐬𝐞𝐬
🔗 𝐑𝐞𝐚𝐝 𝐭𝐡𝐞 𝐟𝐮𝐥𝐥 𝐚𝐫𝐭𝐢𝐜𝐥𝐞 𝐡𝐞𝐫𝐞: https://bit.ly/4iZ0cPk
#BrainMetastases #LungCancer # #Genomics #CancerResearch #ResearchInsight #BenthamScience
@wchanna.bsky.socialOctober is Healthy Lung Month, a timely reminder that lung health deserves our attention. From prevention and early detection to better diagnosis and treatment, every step matters when it comes to protecting lung health and improving outcomes.
@alliance-org.bsky.socialNew lung cancer trial open 🧪🫁
Alliance A082402 is studying if targeted post op radiation (I² PORT) can reduce recurrence in high risk #NSCLC patients after surgery while limiting side effects. Learn more https://bit.ly/I-PORT-Trial. #LungCancer #ClinicalTrials #RadiationTherapy
@vcclibrary.bsky.socialCurrent challenges and emerging therapeutic strategies in #LungCancer care: Insights from Bridging the Gaps 2025. acsjournals.onlinelibrary.wiley.com/doi/10.1002/...
@lancetrespirmed.bsky.social🫁 Explore our October 2026 issue, out now in print and online! www.thelancet.com/issue/S2213-...
🔹 This issue features our new Series on therapeutics in #lungcancer, the economic burden of #asthma, #tuberculosis in Ukraine, and much more
@francejeunes.bsky.socialCancer en France : les plus modestes plus exposés et moins dépistés ❓ Le risque de cancer dépend-il des revenus ? ❓ Le cancer du poumon touche-t-il plus les modestes ? ❓ Combien de salariés sont exposés aux cancérogènes ? ❓ Les modestes se font-ils moins dépister ? #france #cancer #lungcancer
@rcatanho.bsky.socialIntegrar encuestas de antec de tabaquismo en mamografía de cribado y procesamiento automatizado de historias médicas electrónicas para capturar antec tabaquismo puede mejorar identificación de candidatas para cribado CA pulmón #EHR #LungCancer #Screening newsletter.smartbrief.com/sharedSummar...
@go2forlungcancer.bsky.socialWe’re leaving our GO2 Centers of Excellence Lung Cancer Screening and Care Conference energized by the people and progress shaping the future of #LungCancer care!
There’s so much reason for hope, and important work ahead. Watch Dave’s recap from San Diego.
@onecuriousoul.bsky.socialLIGHT UP AND DIE: THE SMOKING ADDICTION! -- a Bill's Bible Basics article
#CigaretteSmoking #Smoking #LungCancer
This Bill’s Bible Basics 2-part article can be read at: https://www.billkochman.com/Articles/index-new.html
@lungcancereurope.bsky.socialThe link between #lungcancer and heart health runs both ways. The conditions share risks, and some lung cancer treatments can affect the heart.
More on the evidence and what it means for care this #WorldHeartDay: lungcancereurope.eu/news/lung-ca... #LCSM
@pulmonologyadvisor.bsky.socialFrom @accpchest.bsky.social Journal 🫁
Although incidental #emphysema detected via routine chest CT correlates with higher all-cause and #LungCancer-specific mortality risk, it does not independently stratify patient prognosis beyond known smoking history. #PulmSky #OncSky
@thelancetoncol.bsky.social🆕Our October issue is live!
📊Articles: #ovariancancer, #breastcancer, #multiplemyeloma, #prostatecancer, #lungcancer
📉Trials: KEYLYNK-001, CHN HYPOPMRT, SYMPRO-Lung trial, OPTIMUM/MUKnine, STAMINA
🎨Cover: Cancer & the microbiome
Read here: thelancet.com/issue/S1470-...
@med-news.bsky.socialCHI Health St. Francis , in partnership with the Central District Health Department, invites the community to "Understanding Radon" from noon-1 p.m. on Tuesday, Oct. 6, in Conference Room 6 A/B at the hospital.
@phenomics.bsky.social🫁 A Phenomics New Highlights article explores how bronchoalveolar lavage fluid microbiome signatures may inform lung cancer diagnosis, subtype classification and prognosis.
@eaonc.bsky.social#ClinicalTrial EA5221/ACHIEVE, led by Dr. Megan Baumgart, aims to help older patients with #LungCancer live longer while also maintaining a good quality of life. Learn more: https://bit.ly/ea5221-achieve #NSCLC #LCSM
@duboisrn.bsky.socialRare Inherited Genetic #Mutation Is One of Strongest Indicators Yet for #LungCancer #Risk: hms.harvard.edu/news/rare-in...
@btog.bsky.socialSelected key takeaway from our 2026 Annual Conference: AI Support in Clinical Decision Making presented by Arsela Prelaj. Full recordings and presentations available to members on our website. #LCSM #lungcancer
@myesmo.bsky.social👉 In this #ESMOGuidelines webinar, we explore the ESMO Clinical Practice Guidelines for early stage and locally advanced #NSCLC, applying key recommendations to a real-world case in multidisciplinary #LungCancer care
